6YR5 image
Entry Detail
PDB ID:
6YR5
Title:
14-3-3 sigma in complex with hDMX-367 peptide
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2020-04-19
Release Date:
2021-11-03
Method Details:
Experimental Method:
Resolution:
2.25 Å
R-Value Free:
0.22
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
P 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:14-3-3 protein sigma
Chain IDs:A, C (auth: B), E (auth: C), G (auth: D)
Chain Length:236
Number of Molecules:4
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Protein Mdm4
Chain IDs:B (auth: O), D (auth: P), F (auth: Q), H (auth: R)
Chain Length:14
Number of Molecules:4
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
SEP B SER modified residue
Ligand Molecules
Primary Citation
Understanding the interaction of 14-3-3 proteins with hDMX and hDM2: a structural and biophysical study.
Febs J. ? ? ? (2022)
PMID: 35286747 DOI: 10.1111/febs.16433

Abstact

p53 plays a critical role in regulating diverse biological processes: DNA repair, cell cycle arrest, apoptosis and senescence. The p53 pathway has therefore served as the focus of multiple drug-discovery efforts. p53 is negatively regulated by hDMX and hDM2; prior studies have identified 14-3-3 proteins as hDMX and hDM2 client proteins. 14-3-3 proteins are adaptor proteins that modulate localization, degradation and interactions of their targets in response to phosphorylation. Thus, 14-3-3 proteins may indirectly modulate the interaction between hDMX or hDM2 and p53 and represent potential targets for modulation of the p53 pathway. In this manuscript, we report on the biophysical and structural characterization of peptide/protein interactions that are representative of the interaction between 14-3-3 and hDMX or hDM2. The data establish that proximal phosphosites spaced ~20-25 residues apart in both hDMX and hDM2 co-operate to facilitate high-affinity 14-3-3 binding and provide structural insight that can be utilized in future stabilizer/inhibitor discovery efforts.

Legend

Protein

Chemical

Disease

Primary Citation of related structures